Of note, MALAT1 expression levels were increased in docetaxel (DTX)-resistant AR-negative PC3 and DU-145 cells, and DTX-resistant PCa patient tumours, and its overexpression enhanced DTX-chemoresistance in vivo. Here, AR is linked to posterior cortical atrophy.